vs

Side-by-side financial comparison of EVI INDUSTRIES, INC. (EVI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

EVI INDUSTRIES, INC. is the larger business by last-quarter revenue ($115.3M vs $83.1M, roughly 1.4× PROCEPT BioRobotics Corp). EVI INDUSTRIES, INC. runs the higher net margin — 2.1% vs -38.1%, a 40.1% gap on every dollar of revenue. On growth, EVI INDUSTRIES, INC. posted the faster year-over-year revenue change (24.4% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 17.2%).

EVI Industries, Inc. is a leading distributor of commercial laundry, dry cleaning, and garment care equipment, as well as related parts and supplies. It primarily serves commercial customers across North America, including laundromats, hospitality businesses, healthcare facilities, and multi-family housing properties, offering installation, maintenance and after-sales support services.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

EVI vs PRCT — Head-to-Head

Bigger by revenue
EVI
EVI
1.4× larger
EVI
$115.3M
$83.1M
PRCT
Growing faster (revenue YoY)
EVI
EVI
+4.2% gap
EVI
24.4%
20.2%
PRCT
Higher net margin
EVI
EVI
40.1% more per $
EVI
2.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
17.2%
EVI

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
EVI
EVI
PRCT
PRCT
Revenue
$115.3M
$83.1M
Net Profit
$2.4M
$-31.6M
Gross Margin
30.8%
64.9%
Operating Margin
3.7%
-4.1%
Net Margin
2.1%
-38.1%
Revenue YoY
24.4%
20.2%
Net Profit YoY
109.9%
-27.9%
EPS (diluted)
$0.15
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EVI
EVI
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$115.3M
$76.4M
Q3 25
$108.3M
$83.3M
Q2 25
$110.0M
$79.2M
Q1 25
$93.5M
$69.2M
Q4 24
$92.7M
$68.2M
Q3 24
$93.6M
$58.4M
Q2 24
$90.1M
$53.4M
Net Profit
EVI
EVI
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$2.4M
$-29.8M
Q3 25
$1.8M
$-21.4M
Q2 25
$2.1M
$-19.6M
Q1 25
$1.0M
$-24.7M
Q4 24
$1.1M
$-18.9M
Q3 24
$3.2M
$-21.0M
Q2 24
$2.1M
$-25.6M
Gross Margin
EVI
EVI
PRCT
PRCT
Q1 26
64.9%
Q4 25
30.8%
60.6%
Q3 25
31.3%
64.8%
Q2 25
30.8%
65.4%
Q1 25
30.0%
63.9%
Q4 24
29.7%
64.0%
Q3 24
30.8%
63.2%
Q2 24
30.4%
59.0%
Operating Margin
EVI
EVI
PRCT
PRCT
Q1 26
-4.1%
Q4 25
3.7%
-40.6%
Q3 25
3.3%
-27.8%
Q2 25
3.7%
-28.0%
Q1 25
2.4%
-39.7%
Q4 24
2.6%
-28.9%
Q3 24
5.3%
-38.4%
Q2 24
4.1%
-50.3%
Net Margin
EVI
EVI
PRCT
PRCT
Q1 26
-38.1%
Q4 25
2.1%
-39.1%
Q3 25
1.7%
-25.7%
Q2 25
1.9%
-24.7%
Q1 25
1.1%
-35.8%
Q4 24
1.2%
-27.6%
Q3 24
3.5%
-35.9%
Q2 24
2.3%
-48.0%
EPS (diluted)
EVI
EVI
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.15
$-0.54
Q3 25
$0.11
$-0.38
Q2 25
$0.14
$-0.35
Q1 25
$0.07
$-0.45
Q4 24
$0.07
$-0.34
Q3 24
$0.21
$-0.40
Q2 24
$0.13
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EVI
EVI
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$144.0M
$347.7M
Total Assets
$315.6M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EVI
EVI
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$4.7M
$294.3M
Q2 25
$8.9M
$302.7M
Q1 25
$5.9M
$316.2M
Q4 24
$3.9M
$333.7M
Q3 24
$4.4M
$196.8M
Q2 24
$4.6M
$214.1M
Total Debt
EVI
EVI
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$24.0M
$51.5M
Q4 24
$27.9M
$51.5M
Q3 24
$19.9M
$51.4M
Q2 24
$12.9M
$51.4M
Stockholders' Equity
EVI
EVI
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$144.0M
$365.9M
Q3 25
$140.8M
$380.3M
Q2 25
$143.5M
$385.8M
Q1 25
$140.2M
$389.2M
Q4 24
$138.0M
$402.2M
Q3 24
$136.1M
$241.2M
Q2 24
$136.6M
$251.8M
Total Assets
EVI
EVI
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$315.6M
$508.1M
Q3 25
$321.8M
$511.5M
Q2 25
$307.0M
$513.1M
Q1 25
$251.8M
$519.4M
Q4 24
$248.8M
$534.0M
Q3 24
$245.5M
$374.1M
Q2 24
$230.7M
$374.4M
Debt / Equity
EVI
EVI
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.17×
0.13×
Q4 24
0.20×
0.13×
Q3 24
0.15×
0.21×
Q2 24
0.09×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EVI
EVI
PRCT
PRCT
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.70×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EVI
EVI
PRCT
PRCT
Q1 26
Q4 25
$4.0M
$-10.3M
Q3 25
$1.0M
$-6.6M
Q2 25
$9.9M
$-15.0M
Q1 25
$9.1M
$-17.0M
Q4 24
$2.0M
$-32.4M
Q3 24
$207.0K
$-18.8M
Q2 24
$12.4M
$-15.7M
Free Cash Flow
EVI
EVI
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-890.0K
$-9.5M
Q2 25
$8.2M
$-17.8M
Q1 25
$8.1M
$-18.8M
Q4 24
$1.1M
$-33.6M
Q3 24
$-1.0M
$-19.0M
Q2 24
$11.2M
$-16.8M
FCF Margin
EVI
EVI
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-0.8%
-11.4%
Q2 25
7.5%
-22.5%
Q1 25
8.7%
-27.2%
Q4 24
1.2%
-49.2%
Q3 24
-1.1%
-32.6%
Q2 24
12.4%
-31.4%
Capex Intensity
EVI
EVI
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
1.8%
3.4%
Q2 25
1.5%
3.5%
Q1 25
1.1%
2.7%
Q4 24
0.9%
1.7%
Q3 24
1.3%
0.4%
Q2 24
1.3%
2.0%
Cash Conversion
EVI
EVI
PRCT
PRCT
Q1 26
Q4 25
1.70×
Q3 25
0.55×
Q2 25
4.74×
Q1 25
8.79×
Q4 24
1.74×
Q3 24
0.06×
Q2 24
5.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EVI
EVI

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons